GLRA
IHE icon

Gerald L. Ray & Associates’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Gerald L. Ray & Associates’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$574K Buy
11,007
+3,240
+42% +$166K 0.07% 217
2017
Q2 		$402K Buy
7,767
+450
+6% +$22.7K 0.05% 246
2017
Q1 		$368K Buy
7,317
+2,010
+38% +$99.5K 0.05% 245
2016
Q4 		$250K Buy
+5,307
New +$252K 0.04% 278

Other funds holding IHE

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
RTS
Round Table Services Westfield, New Jersey $508M AUM 16.36% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gerald L. Ray & Associates's IHE Position: Q3 2017 in Review

Gerald L. Ray & Associates increased its iShares US Pharmaceuticals ETF (IHE) stake by 42% in Q3 2017, buying an estimated $166K and bringing the position to 11,007 shares worth $574K. The position accounts for 0.07% of the portfolio, ranked #217.

Gerald L. Ray & Associates first reported a position in IHE in Q4 2016 and has held it in 4 quarters since. 101 funds tracked by Wall St. Rank hold IHE as of Q3 2017.

  • Gerald L. Ray & Associates held 11,007 shares of iShares US Pharmaceuticals ETF worth $574K as of Q3 2017.
  • Gerald L. Ray & Associates bought 3,240 iShares US Pharmaceuticals ETF shares in Q3 2017, an estimated $166K.
  • iShares US Pharmaceuticals ETF made up 0.07% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #217 holding.
  • Gerald L. Ray & Associates first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and has held it in 4 quarters since.
  • 101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.